The biomedical giant best known for its Cologuard at-home colon cancer screening test reported a loss of $38.2 million, or $0.21 per share, on revenue of $708.7 million.
Donald Trump scored a decisive victory in a deeply divided nation. And in the process, the Republican president-elect exposed a weakness within the Democratic base. He also beat back concerns ...
CORALVILLE — Seventh-seeded Cedar Falls went toe-to-toe with Ankeny Centennial, arguably the second-best team in the State this year. In the e… State tournament play opens up with Class 5A and 4A ...